Hadar Levy - 18 Mar 2026 Form 3 Insider Report for Brainsway Ltd. (BWAY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 16:03:38 UTC
Prior SEC filing
07 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Hadar Levy

Key filing fact

Hadar Levy filed Form 3 for Brainsway Ltd. (BWAY) on 18 Mar 2026.

Key facts

  • This page summarizes Hadar Levy's Form 3 filing for Brainsway Ltd. (BWAY).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 16:03.

Change

  • Previous filing in this sequence was filed on 07 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001943548 Primary reporting owner

Levy Hadar

Relationship
Chief Executive Officer
Address
16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL
Signature
/s/ Hadar Levy
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWAY holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
123,050
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BWAY holding Derivative

Stock Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
80,000
Exercise price
Footnotes
F1, F3, F4
BWAY holding Derivative

Stock Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
62,500
Exercise price
Footnotes
F1, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

This figure includes: (i) 16,800 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 31,250 ordinary shares vesting in equal quarterly installments until March 5, 2028 and (b) RSUs to receive 75,000 ordinary shares vesting in equal yearly installments until March 9, 2029, subject to certain vesting conditions.

Footnote F3

Stock options were granted on February 9, 2023, with the remaining options to purchase 80,000 ordinary shares vesting in equal quarterly installments until February 13, 2027, with acceleration in the event of a change of control.

Footnote F4

The exercise price is NIS 3.65 per share.

Footnote F5

Stock options were granted on March 5, 2024, with the remaining options to purchase 62,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.

Footnote F6

The exercise price is NIS 11.17 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .